Atrás
También listada como
IPSEF
OTC
Rango del Día
$43.09
$49.45
Rango de 52 Semanas
$25.11
$49.45
Volumen
1
Promedio 50D / 200D
$42.78
/
$35.78
Cierre Anterior
$43.09
Quick Summary
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (631 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | 133.5 | 0.3 |
| P/B | 13.2 | 3.0 |
| ROE % | 10.0 | 3.7 |
| Net Margin % | 12.1 | 3.8 |
| Rev Growth 5Y % | 6.5 | 10.0 |
| D/E | 0.2 | 0.2 |
Precio Objetivo de Analistas
No hay cobertura de analistas disponible
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2030 |
$3.84
$3.50 – $4.11
|
4.75B | 1 |
| FY2029 |
$3.70
$3.36 – $3.95
|
4.62B | 1 |
| FY2028 |
$3.27
$2.97 – $3.50
|
4.59B | 1 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-12 | $1.64 | $0.39 | -76.3% |
| 2025-06-30 | $1.63 | $1.18 | -27.6% |
| 2024-12-31 | N/A | $0.35 | — |
| 2024-06-29 | $1.26 | $0.75 | -40.7% |
| 2023-12-31 | $1.42 | $1.48 | +4.2% |
| 2023-06-30 | $1.37 | $0.64 | -53.2% |
| 2022-12-31 | $1.34 | $0.83 | -38.4% |
| 2022-06-30 | $1.11 | $1.24 | +11.7% |
Dividend History
Yield
0.01%
Payout Ratio
N/A
Growth (3Y)
N/A
Growth (5Y)
N/A
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Jun 09, 2025 | Jun 25, 2025 | $0.40 | 1.34% |
| May 31, 2024 | Jun 14, 2024 | $0.33 | 1.00% |
| Jun 02, 2023 | Jun 21, 2023 | $0.32 | 1.09% |
| May 31, 2022 | Jun 09, 2022 | $0.32 | 1.28% |
| May 28, 2021 | Jun 09, 2021 | $0.30 | 1.18% |
| Jun 03, 2020 | Jun 12, 2020 | $0.28 | 1.35% |
| May 31, 2019 | Jun 20, 2019 | $0.28 | 0.93% |
| Jun 04, 2018 | Jun 21, 2018 | $0.29 | 0.77% |
| Jun 08, 2017 | Jul 11, 2017 | $0.24 | 0.70% |
| May 31, 2016 | Jul 13, 2016 | $0.24 | 1.50% |
| May 26, 2015 | Jul 06, 2015 | $0.24 | 1.76% |
| Jun 04, 2014 | Jul 02, 2014 | $0.27 | 2.25% |
| May 31, 2013 | Jul 08, 2013 | $0.26 | 3.00% |
| Jun 01, 2012 | Jun 18, 2012 | $0.19 | 4.62% |
| May 26, 2011 | Jun 13, 2011 | $0.29 | 3.89% |
Puntos Clave
Revenue grew 6.46% annually over 5 years — modest growth
Earnings grew 23.43% over the past year
ROE of 10.03% — decent returns on equity
Debt/Equity of 0.24 — conservative balance sheet
Generating 992.33M in free cash flow
P/E of 133.45 — premium valuation
Crecimiento
Revenue Growth (5Y)
6.46%
Revenue (1Y)-1.22%
Earnings (1Y)23.43%
FCF Growth (3Y)20.54%
Calidad
Return on Equity
10.03%
ROIC9.98%
Net Margin12.09%
Op. Margin20.30%
Seguridad
Debt / Equity
0.24
Current Ratio1.96
Interest Coverage20.67
Valoración
P/E Ratio
133.45
Forward P/EN/A
P/B Ratio13.15
EV/EBITDA78.83
Dividend Yield0.01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -1.22% | Revenue Growth (3Y) | 3.34% |
| Earnings Growth (1Y) | 23.43% | Earnings Growth (3Y) | -18.60% |
| Revenue Growth (5Y) | 6.46% | Earnings Growth (5Y) | -9.86% |
| Profitability | |||
| Revenue (TTM) | 3.53B | Net Income (TTM) | 426.96M |
| ROE | 10.03% | ROA | 6.16% |
| Gross Margin | 70.58% | Operating Margin | 20.30% |
| Net Margin | 12.09% | Free Cash Flow (TTM) | 992.33M |
| ROIC | 9.98% | FCF Growth (3Y) | 20.54% |
| Safety | |||
| Debt / Equity | 0.24 | Current Ratio | 1.96 |
| Interest Coverage | 20.67 | ||
| Dividends | |||
| Dividend Yield | 0.01% | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 133.45 | Forward P/E | N/A |
| P/B Ratio | 13.15 | P/S Ratio | 16.14 |
| PEG Ratio | 1.09 | Forward PEG | N/A |
| EV/EBITDA | 78.83 | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | 1.74% | ||
| Market Cap | 56.98B | Enterprise Value | 56.51B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 3.53B | 3.57B | 3.31B | 3.16B | 2.75B |
| Net Income | 426.96M | 345.90M | 644.40M | 648.60M | 646.60M |
| EPS (Diluted) | 1.28 | 1.04 | 1.85 | 1.79 | 1.89 |
| Gross Profit | 2.49B | 2.96B | 2.74B | 2.63B | 2.31B |
| Operating Income | 716.85M | 496.70M | 816.00M | 729.90M | 824.70M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 6.93B | 6.44B | 6.32B | 5.61B | 5.01B |
| Total Liabilities | 2.60B | 2.26B | 2.50B | 2.27B | 2.25B |
| Shareholders' Equity | 4.33B | 4.18B | 3.83B | 3.34B | 2.74B |
| Total Debt | 1.05B | 426.80M | 373.50M | 771.60M | 693.10M |
| Cash & Equivalents | 1.52B | 678.10M | 528.40M | 1.17B | 814.70M |
| Current Assets | 2.82B | 2.02B | 1.90B | 2.40B | 1.95B |
| Current Liabilities | 1.44B | 1.51B | 1.63B | 1.34B | 1.23B |